 |
|
|
| |
Telaprevir combination therapy in treatment-naïve and experienced patients co-infected with HCV and HIV
|
| |
| |
Reported by Jules Levin
AASLD 2013 Nov 1-5 Wash DC
Marisa Montes1, Mark Nelson2, Marie Girard3, Joe Sasadeusz4, Andrzej Horban5, Beatriz Grinsztejn6, Natalia Zakharova7, Karolin Falconer8, Inge Dierynck9, Donghan Luo10, Yi-Wen Ma10, James Witek10
1. Hospital La Paz, Madrid, Spain.
2. Chelsea and Westminster Hospital, London, United Kingdom.
3. Hopital St Antoine, Paris, France.
4. Victorian Infectious Diseases Service, Royal Melbourne Hospital, Melbourne, VIC, Australia.
5. Hospital of Infectious Diseases, Warsaw, Poland.
6. STD/AIDS Clinical Research Laboratory, Instituto de Pesquisa Clínica Evandro Chagas, Rio de Janeiro, Brazil.
7. Saint-Petersburg AIDS Center, St. Petersburg, Russian Federation.
8. Karolinska University Hospital, Stockholm, Sweden.
9. Janssen Infectious Diseases BVBA, Beerse, Belgium.
10. Janssen Research & Development LLC, Titusville, NJ, United States.
|
| |
|
|
|
|
|
